Clinical Trial Update: Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV [Phase 3]

View source ↗

Summary

Clinical trial update on a nine-valent HPV vaccine intended to prevent persistent oral HPV infection in men with HIV; the Phase 3 study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Human Papillomavirus Infection
• Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: HPV Positive Oropharyngeal Squamous Cell Carcinoma, HIV-1-infection | Phase 3 | Status: ACTIVE_NOT_RECRUITING